CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -50.0% | 183 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | +100.0% | 183 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 183 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 183 | -17.6% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 222 | -2.6% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 228 | +24.6% | 0.00% | – |
| Q4 2021 | $6,000 | -25.0% | 183 | +69.4% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | – | 108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $230,000,000 | 35.34% |
| Affinity Asset Advisors, LLC | 150,000 | $11,022,000 | 3.95% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 132,300 | $9,722,000 | 0.79% |
| Renaissance Capital LLC | 56,915 | $4,182,000 | 0.66% |
| QCM Cayman, Ltd. | 2,744 | $202,000 | 0.52% |
| Green Alpha Advisors, LLC | 4,545 | $334,000 | 0.23% |
| Baillie Gifford | 5,515,262 | $405,261,000 | 0.20% |
| CSS LLC/IL | 60,000 | $4,408,000 | 0.18% |
| Caption Management, LLC | 161,400 | $11,860,000 | 0.16% |
| MANGROVE PARTNERS IM, LLC | 20,200 | $1,484,000 | 0.15% |